Recruiting

Vinoperfect

Sponsor:

Weill Medical College of Cornell University

Code:

NCT07896486

Conditions

Post-inflammatory Hyperpigmentation

Post-acne Hyperpigmentation

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Vinoperfect brightening serum

Study Details

Brief summary:

This study is designed to evaluate the effectiveness and safety of Vinoperfect, a skin-brightening serum, for treating post-inflammatory hyperpigmentation (PIH), or dark spots that can develop after acne, in participants with Fitzpatrick Skin Types IV-VI (medium to deep skin tones). The study will assess Vinoperfect as part of a comprehensive skincare routine that includes cleansing, treatment, moisturization, and protection from sunlight.

Conditions

Post-inflammatory Hyperpigmentation

Post-acne Hyperpigmentation

Study ID

NCT07896486

Start date

Nov 4, 2026

Status verified date

Nov, 2026

Completion date

Jan 15, 2027

Anticipated

Primary completion date

Jan 15, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Male or female participants aged ≥18 years.
2. Participants with Fitzpatrick Skin Types IV, V, or VI.
3. Participants of any ethnicity.
4. Presenting with moderate to severe post-inflammatory hyperpigmentation, as determined by a PAHPI score of 8 or higher.
5. Presenting with history or presence of mild acne, as indicated by a Global Acne Severity Score of 2 or lower (GEA ≤ 2).
6. Capable of understanding and communicating in English, and willing to provide written informed consent to participate in the study.
7. Willing to comply with study requirements, including attending all scheduled in-person follow-up visits as outlined in the protocol.
8. Willing to undergo facial photography.
9. Willing to undergo facial examination for clinical evaluation.
10. In good general health, free of any other dermatologic conditions that may interfere with the assessment of the treated area.
11. Willing to refrain from using any other facial skincare products during the study period.
12. Willing to avoid excessive sun exposure and tanning beds during the study period.
13. Willing to refrain from undergoing chemical peels, laser rejuvenation, or hair removal treatments during the study period.
14. For females of childbearing potential: willing to use at least one reliable form of contraception, defined as stable use of oral or systemic contraceptives for at least 6 months prior to Day 1 of the study and throughout the study duration.

Exclusion Criteria:

1. Participants with Fitzpatrick Skin Types I, II, or III.
2. Pregnant or breastfeeding participants.
3. Individuals presenting with moderate to very severe acne, as indicated by a Global Acne Severity Score of 3 or higher (GEA > 3).
4. Participants with known allergies or sensitivities to any active or inactive ingredients in the study products.
5. Participants with dermatologic conditions that may interfere with the evaluation of the treatment area.
6. Individuals with regular sun exposure or frequent use of tanning salons.
7. Participants currently enrolled in another clinical study.
8. Participants who have used the following treatments or procedures within a specific washout periods (to be discussed with the study investigators).

Study Design

Enrollment

20 participants

Anticipated

Intervention Model

Single group

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

other: Participants with Acne-Associated Post-Inflammatory Hyperpigmentation using the Vinoperfect Serum

Participants will undergo a standardized twice-daily skincare regimen for 12 weeks. In the morning, participants will cleanse their face, apply the Vinoperfect Brightening Serum, apply moisturizer, and then apply SPF 50+ sunscreen. In the evening, participants will cleanse their face, apply the Vinoperfect Brightening Serum, and apply moisturizer.

Interventions

Vinoperfect brightening serum

Participants will undergo a standardized twice-daily skincare regimen for 12 weeks. In the morning, participants will cleanse their face, apply the Vinoperfect Brightening Serum, apply moisturizer, and then apply SPF 50+ sunscreen. In the evening, participants will cleanse their face, apply the Vinoperfect Brightening Serum, and apply moisturizer.

Primary outcome measure

  • Change from baseline in PIH of the face at Week 12, as assessed by the Post-Acne Hyperpigmentation Index (PAHPI) score [ Time Frame: Baseline; 12 weeks ]

Central Contacts and Locations

Central contacts

Locations

Weill Cornell Medicine Dermatology

Recruiting

New York, New York, United States, 10022

Contacts

Olumayowa Adebiyi, MD, MHS

6469626054dermres@med.cornell.edu

Principal Investigator:

Andrew Alexis, MD, MPH

More Information

Sponsor

Weill Medical College of Cornell University

Last update posted

Nov 18, 2026

Last verified

Nov, 2026

Keywords

  • Post-Inflammatory Hyperpigmentation
  • post-acne hyperpigmentation
  • acne
  • hyperpigmentation
  • skin of color
  • FST

Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-19. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2026-11-18. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.